Grace Hamilton, a study participant who has been on GLP-1s since her early 20s, said she has noticed several impactful changes to her brain since being on the medication
In addition to the two primary uses for retatrutide, Lilly said it is evaluating the drug's potential for a host of obesity-related medical conditions, including knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal issues, and metabolic dysfunction-associated steatotic liver disease
Alcohol use compounds this
If the BALANCE Model launches in some future year with at least 80% participation, Part D plans could drop out of the model before the final year (originally 2031), which could interrupt treatment, or require frequent plan changes for Medicare Part D enrollees to maintain access
First, the starting dose matters more than the maintenance dose for determining your side effect experience
Pietrocola et al., 2015)